Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

GATA Factor-Regulated Samd14 Enhancer Confers Red Blood Cell Regeneration and Survival in Severe Anemia.

Developmental cell | 2017

An enhancer with amalgamated E-box and GATA motifs (+9.5) controls expression of the regulator of hematopoiesis GATA-2. While similar GATA-2-occupied elements are common in the genome, occupancy does not predict function, and GATA-2-dependent genetic networks are incompletely defined. A "+9.5-like" element resides in an intron of Samd14 (Samd14-Enh) encoding a sterile alpha motif (SAM) domain protein. Deletion of Samd14-Enh in mice strongly decreased Samd14 expression in bone marrow and spleen. Although steady-state hematopoiesis was normal, Samd14-Enh-/- mice died in response to severe anemia. Samd14-Enh stimulated stem cell factor/c-Kit signaling, which promotes erythrocyte regeneration. Anemia activated Samd14-Enh by inducing enhancer components and enhancer chromatin accessibility. Thus, a GATA-2/anemia-regulated enhancer controls expression of an SAM domain protein that confers survival in anemia. We propose that Samd14-Enh and an ensemble of anemia-responsive enhancers are essential for erythrocyte regeneration in stress erythropoiesis, a vital process in pathologies, including β-thalassemia, myelodysplastic syndrome, and viral infection.

Pubmed ID: 28787589 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

Associated grants

  • Agency: NHLBI NIH HHS, United States
    Id: T32 HL007936
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK050107
  • Agency: NCI NIH HHS, United States
    Id: P30 CA014520
  • Agency: NIDDK NIH HHS, United States
    Id: K01 DK113117
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK080040
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK068634
  • Agency: NIGMS NIH HHS, United States
    Id: P41 GM108538
  • Agency: NIDDK NIH HHS, United States
    Id: R37 DK050107
  • Agency: NIDDK NIH HHS, United States
    Id: R56 DK068634

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


New England Biolabs (tool)

RRID:SCR_013517

An Antibody supplier

View all literature mentions

APC anti-mouse Ki-67 (antibody)

RRID:AB_2561929

This monoclonal targets Ki-67

View all literature mentions

goat anti-rabbit IgG-HRP (antibody)

RRID:AB_631746

This polyclonal targets goat anti-rabbit IgG-HRP

View all literature mentions

Anti-Mouse CD34 Alexa Fluor® 647 (To Be Discontinued. Refer to NEW Format: eFluor® 660, cat. 50-0341) 100 ug (antibody)

RRID:AB_657739

This unknown targets Mouse CD34 Alexa Fluor® 647 (To Be Discontinued. Refer to NEW Format: eFluor® 660 cat. 50-0341) 100 ug

View all literature mentions